X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3029) 3029
male (2081) 2081
non-alcoholic fatty liver disease (1944) 1944
animals (1742) 1742
fatty liver (1671) 1671
liver diseases (1483) 1483
female (1300) 1300
gastroenterology & hepatology (1253) 1253
liver (1233) 1233
non-alcoholic fatty liver disease - drug therapy (1175) 1175
insulin-resistance (1113) 1113
insulin resistance (1039) 1039
obesity (983) 983
middle aged (968) 968
liver - metabolism (947) 947
metabolic syndrome (930) 930
liver - pathology (925) 925
mice (890) 890
non-alcoholic fatty liver disease - metabolism (833) 833
fibrosis (822) 822
adult (812) 812
steatohepatitis (796) 796
steatosis (794) 794
nonalcoholic steatohepatitis (771) 771
fatty liver-disease (767) 767
risk factors (765) 765
liver - drug effects (759) 759
hepatic steatosis (758) 758
inflammation (742) 742
non-alcoholic fatty liver disease - pathology (714) 714
oxidative stress (659) 659
nafld (583) 583
metabolism (572) 572
diet (520) 520
diabetes (513) 513
non-alcoholic steatohepatitis (511) 511
mice, inbred c57bl (503) 503
pharmacology & pharmacy (499) 499
nonalcoholic fatty liver disease (489) 489
disease models, animal (485) 485
analysis (480) 480
rats (474) 474
prevalence (467) 467
fatty liver - drug therapy (463) 463
lipids (460) 460
rodents (453) 453
aged (448) 448
gastroenterology and hepatology (419) 419
non-alcoholic fatty liver disease - complications (418) 418
non-alcoholic fatty liver disease - etiology (417) 417
endocrinology & metabolism (412) 412
fatty acids (406) 406
insulin (405) 405
disease (392) 392
biopsy (386) 386
treatment outcome (376) 376
care and treatment (371) 371
non-alcoholic fatty liver disease - blood (371) 371
cholesterol (357) 357
fatty liver - metabolism (355) 355
non-alcoholic fatty liver disease - diagnosis (355) 355
health aspects (346) 346
liver cirrhosis (342) 342
biochemistry & molecular biology (340) 340
pathogenesis (332) 332
glucose (331) 331
nutritional and metabolic diseases (331) 331
nutrition & dietetics (327) 327
non-alcoholic fatty liver disease - epidemiology (325) 325
cirrhosis (321) 321
diet, high-fat - adverse effects (321) 321
fatty liver - pathology (321) 321
expression (318) 318
nash (318) 318
hepatology (316) 316
digestive system diseases (312) 312
type 2 diabetes (308) 308
hepatocellular-carcinoma (303) 303
lipid metabolism (302) 302
gene expression (301) 301
disease progression (297) 297
medicine (296) 296
non-alcoholic fatty liver disease - therapy (293) 293
physiological aspects (293) 293
body mass index (290) 290
non-alcoholic fatty liver disease - genetics (290) 290
lipid metabolism - drug effects (289) 289
review (289) 289
triglycerides (288) 288
research (285) 285
medicine, research & experimental (274) 274
obesity - complications (274) 274
diagnosis (273) 273
hepatitis (272) 272
development and progression (271) 271
vitamin-e (267) 267
diabetes mellitus (265) 265
biomarkers - blood (263) 263
research article (261) 261
risk (259) 259
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4407) 4407
Chinese (57) 57
Russian (39) 39
Japanese (24) 24
Spanish (16) 16
German (15) 15
Ukrainian (11) 11
French (9) 9
Portuguese (8) 8
Hungarian (6) 6
Korean (6) 6
Norwegian (3) 3
Czech (2) 2
Italian (2) 2
Persian (2) 2
Dutch (1) 1
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
PloS one, ISSN 1932-6203, 2014, Volume 9, Issue 2, p. e88005
Introduction: Nonalcoholic fatty liver disease (NAFLD) is one of the most important causes of liver-related morbidity and mortality in children... 
SUPPLEMENTATION | ACTIVATION | OBESITY | BILIARY TREE | GPR120 | THERAPY | MULTIDISCIPLINARY SCIENCES | MOUSE | VALIDATION | HEPATIC STEATOSIS | CHILDREN | Inflammation - pathology | Liver - pathology | Receptors, G-Protein-Coupled - metabolism | Fatty Liver - pathology | Humans | Hepatocytes - pathology | Male | NF-kappa B - metabolism | Hepatocytes - metabolism | Inflammation - metabolism | Liver - drug effects | Inflammation - drug therapy | Non-alcoholic Fatty Liver Disease | Stem Cells - microbiology | Female | Child | Cytokines - genetics | Hepatocytes - drug effects | Fatty Liver - genetics | Fatty Liver - metabolism | Cytokines - metabolism | Macrophages - pathology | Anti-Inflammatory Agents - pharmacology | Liver - metabolism | Fatty Liver - drug therapy | Docosahexaenoic Acids - pharmacology | Macrophages - metabolism | NF-kappa B - genetics | Adolescent | Inflammation - genetics | Stem Cells - drug effects | Stem Cells - pathology | Macrophages - drug effects | Receptors, G-Protein-Coupled - genetics | Pediatrics | Unsaturated fatty acids | Fatty liver | Analysis | G proteins | Macrophages | Health aspects | Omega-3 fatty acids | Membrane proteins | Oxidative stress | Correlation | Laboratories | Polyunsaturated fatty acids | Liver | Serine | Inflammatory response | Docosahexaenoic acid | Parameter modification | Cell activation | Ultrasonic imaging | Reduction | Rodents | Hepatology | Children | Translocation | NF-κB protein | Liver diseases | Cell survival | Cytokines | Fish oils | Triglycerides | Histology | Inflammation | Metabolism | Fatty acids | Survival | Progenitor cells | Anti-inflammatory agents | Morbidity | Nuclear transport | Children & youth | Steatosis | Weight control | Hospitals | Diet | Hepatocytes | Biopsy | Orthopedics | Stem cells | Cells (biology) | Insulin resistance
Journal Article
Nutrients, ISSN 2072-6643, 2018, Volume 10, Issue 10, p. 1457
.... Gut dysbiosis could increase permeability of the gut barrier, resulting in translocated bacteria and leaked gut-derived products, which can reach the liver through the portal vein and might lead... 
natural products | mechanisms | gut microbiota | hepatoprotection | probiotics | OXIDATIVE STRESS | HIGH-FAT DIET | INTESTINAL BARRIER DYSFUNCTION | HEPATOCELLULAR-CARCINOMA | NUTRITION & DIETETICS | INSULIN-RESISTANCE | MICE | INDUCED OBESITY | BILE-ACIDS | LACTOBACILLUS-RHAMNOSUS GG | HERBAL INFUSIONS | Intestines - drug effects | Non-alcoholic Fatty Liver Disease - pathology | Fibrosis - drug therapy | Liver - pathology | Dysbiosis - drug therapy | Apoptosis - drug effects | Fatty Liver - pathology | Plant Extracts - pharmacology | Humans | Biological Products - pharmacology | Fatty Liver, Alcoholic - prevention & control | Fatty Liver, Alcoholic - metabolism | Liver - drug effects | Fatty Liver - microbiology | Inflammation - drug therapy | Liver Neoplasms - pathology | Fatty Liver, Alcoholic - pathology | Fatty Acids - metabolism | Biological Products - therapeutic use | Liver Neoplasms - prevention & control | Fatty Liver - metabolism | Intestines - pathology | Liver - metabolism | Non-alcoholic Fatty Liver Disease - microbiology | Fatty Liver - prevention & control | Gastrointestinal Microbiome | Non-alcoholic Fatty Liver Disease - metabolism | Dysbiosis - complications | Liver Neoplasms - microbiology | Probiotics | Intestines - microbiology | Diet | Liver Neoplasms - metabolism | Non-alcoholic Fatty Liver Disease - prevention & control | Oxidative Stress - drug effects | Fatty Liver, Alcoholic - microbiology | Plant Extracts - therapeutic use
Journal Article
Molecular aspects of medicine, ISSN 0098-2997, 08/2017, Volume 56, pp. 34 - 44
Nonalcoholic fatty liver disease is growing in prevalence worldwide. It is marked by the presence of macrosteatosis on liver histology but is often clinically asymptomatic... 
Bile acids | Nonalcoholic fatty liver disease (NAFLD) | Farnesoid X receptor (FXR) | Enterohepatic circulation | Gut-liver crosstalk | Nonalcoholic steatohepatitis (NASH) | MEDICINE, RESEARCH & EXPERIMENTAL | SMALL HETERODIMER PARTNER | OBETICHOLIC ACID | INTESTINAL MICROBIOTA | BIOCHEMISTRY & MOLECULAR BIOLOGY | FUNCTIONAL-CHARACTERIZATION | URSODEOXYCHOLIC ACID | SLEEVE GASTRECTOMY | FARNESOID-X-RECEPTOR | CHOLESTEROL 7-ALPHA-HYDROXYLASE | N-ACYLTRANSFERASE | NONOBESE PATIENTS | Liver - pathology | Receptors, Steroid - metabolism | Receptors, G-Protein-Coupled - metabolism | Humans | Receptors, G-Protein-Coupled - agonists | Receptors, Steroid - agonists | Liver Neoplasms - etiology | Non-alcoholic Fatty Liver Disease - complications | Carcinoma, Hepatocellular - drug therapy | Liver - drug effects | Carcinoma, Hepatocellular - genetics | Liver Cirrhosis - metabolism | Carcinoma, Hepatocellular - etiology | Liver Cirrhosis - genetics | Liver Cirrhosis - drug therapy | Liver Cirrhosis - etiology | Liver Neoplasms - genetics | Non-alcoholic Fatty Liver Disease - genetics | Liver - metabolism | Gene Expression Regulation | Liver Neoplasms - drug therapy | Bile Acids and Salts - metabolism | Non-alcoholic Fatty Liver Disease - metabolism | Receptors, Cytoplasmic and Nuclear - agonists | Receptors, Cytoplasmic and Nuclear - genetics | Disease Progression | Azepines - therapeutic use | Non-alcoholic Fatty Liver Disease - drug therapy | Bile Acids and Salts - therapeutic use | Receptors, Steroid - genetics | Liver Neoplasms - metabolism | Glucose - metabolism | Indoles - therapeutic use | Receptors, G-Protein-Coupled - genetics | Isoxazoles - therapeutic use | Energy Metabolism - drug effects | Carcinoma, Hepatocellular - metabolism | Receptors, Cytoplasmic and Nuclear - metabolism | Lipids | Fatty liver | Liver cirrhosis | Deoxycholic acid | Index Medicus
Journal Article
Clinical gastroenterology and hepatology, ISSN 1542-3565, 2014, Volume 12, Issue 12, pp. 2085 - 2091.e1
Journal Article
World journal of gastroenterology : WJG, ISSN 1007-9327, 2014, Volume 20, Issue 39, pp. 14205 - 14218
Journal Article